e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.15p
   
  • Change Today:
    -0.40p
  • 52 Week High: 33.80
  • 52 Week Low: 15.48
  • Currency: UK Pounds
  • Shares Issued: 582.16m
  • Volume: 134,187
  • Market Cap: £94.02m

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 16.15p per share. In the last year e-Therapeutics's share price has ranged from 15.48p to 33.80p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2006.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 197.1 n/a
Pr/Book 3.4  
Latest F'cast
Revenue 50.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

e-Therapeutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-18 n/a (6.72) (2.00)p n/a n/a n/a n/a 0.0%
31-Jan-19 0.04 (5.09) (1.49)p n/a n/a n/a n/a 0.0%
31-Jan-20 0.46 (2.87) (0.87)p n/a n/a n/a n/a 0.0%
31-Jan-21 0.32 (4.47) (0.99)p n/a n/a n/a n/a 0.0%
31-Jan-22 0.48 (9,519.00) (1.65)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

e-Therapeutics Company Announcements

Director Dealing and Issue of Equity 04-Jan-2023 15:15 RNS
Second Price Monitoring Extn 29-Dec-2022 16:40 RNS
Price Monitoring Extension 29-Dec-2022 16:35 RNS

e-Therapeutics ShareCast News

Eight new patent applications filed by e-therape... 01-Aug-2022 ShareCast
E-therapeutics reaches 'key milestone' in Galapa... 12-Apr-2022 ShareCast
E-therapeutics finance chief stepping down due t... 22-Nov-2021 ShareCast

Latest e-Therapeutics Director Deals

Traded Action Notifier PriceAmountValue
04-Jan-23 Buy Trevor Mervyn Jones 17.05p 44,350 £7,561.67

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 16.15p
Change Today -0.40p
% Change -2.42 %
52 Week High 33.80
52 Week Low 15.48
Volume 134,187
Shares Issued 582.16m
Market Cap £94.02m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.06% below the market average31.06% below the market average31.06% below the market average31.06% below the market average31.06% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Price Trend
68.74% below the market average68.74% below the market average68.74% below the market average68.74% below the market average68.74% below the market average
1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average
Income Not Available
Growth
38.39% above the market average38.39% above the market average38.39% above the market average38.39% above the market average38.39% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average

e-Therapeutics Dividends

No dividends found

Trades for 27-Jan-2023

Time Volume / Share Price
13:41 12,300 @ 16.26p
13:24 3,074 @ 16.26p
10:48 615 @ 16.25p
10:47 615 @ 16.25p
10:46 15,606 @ 16.00p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page